Innovative Therapeutic Strategies Targeting the Network Architecture of Glioblastoma

被引：0

作者：

Beichert, Julius ^{[1
]}

Hoffmann, Dirk C. ^{[2
,3
,4
]}

Winkler, Frank ^{[2
,3
,4
]}

Ratliff, Miriam ^{[1
,2
]}

机构：

[1] Heidelberg Univ, Univ Hosp Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany

[2] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Clin Cooperat Unit Neurooncol, Heidelberg, Germany

[3] Univ Hosp Heidelberg, Neurol Clin, Heidelberg, Germany

[4] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany

来源：

CLINICAL CANCER RESEARCH | 2025年 / 31卷 / 14期

关键词：

GLUTAMATE TRANSPORTERS; ADJUNCTIVE PERAMPANEL; CANCER NEUROSCIENCE; GLIOMA-CELLS; BRAIN-TUMORS; PHASE-III; RILUZOLE; GROWTH; SEIZURES; RELEASE;

D O I：

10.1158/1078-0432.CCR-25-0018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent discoveries concerning the network architecture of glioblastoma, including tumor microtubules and neuron-glioma synapses, have underscored critical pathways that sustain tumor growth, enhance resistance, and integrate glioblastoma with the surrounding neural environment. This review explores emerging therapeutic strategies targeting these pathways, including inhibitors of gap junctions, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, and glutamate signaling, which are currently being tested in clinical trials. By consolidating these advances, this review seeks to bridge the gap between neurobiology, cancer neuroscience, and oncology, proposing novel approaches to overcome resistance and improve patient outcomes. The insights derived from this comprehensive review hold the potential to significantly influence the future management of glioblastoma.

引用

页码：2864 / 2871

页数：8

共 78 条

[11] Bradykinin-Induced Chemotaxis of Human Gliomas Requires the Activation of KCa3.1 and ClC-3 [J].

Cuddapah, Vishnu Anand ;

Turner, Kathryn L. ;

Seifert, Stefanie ;

Sontheimer, Harald .

JOURNAL OF NEUROSCIENCE, 2013, 33 (04) :1427-1440

[12] Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas [J].

Drumm, Michael R. ;

Dixit, Karan S. ;

Grimm, Sean ;

Kumthekar, Priya ;

Lukas, Rimas V. ;

Raizer, Jeffrey J. ;

Stupp, Roger ;

Chheda, Milan G. ;

Kam, Kwok-Ling ;

McCord, Matthew ;

Sachdev, Sean ;

Kruser, Timothy ;

Steffens, Alicia ;

Javier, Rodrigo ;

McCortney, Kathleen ;

Horbinski, Craig .

NEURO-ONCOLOGY, 2020, 22 (04) :470-479

[13] Spatial analysis of the glioblastoma proteome reveals specific molecular signatures and markers of survival [J].

Duhamel, Marie ;

Drelich, Lauranne ;

Wisztorski, Maxence ;

Aboulouard, Soulaimane ;

Gimeno, Jean-Pascal ;

Ogrinc, Nina ;

Devos, Patrick ;

Cardon, Tristan ;

Weller, Michael ;

Escande, Fabienne ;

Zairi, Fahed ;

Maurage, Claude-Alain ;

Le Rhun, Emilie ;

Fournier, Isabelle ;

Salzet, Michel .

NATURE COMMUNICATIONS, 2022, 13 (01)

[14] Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis [J].

Eroglu, Cagla ;

Allen, Nicola J. ;

Susman, Michael W. ;

O'Rourke, Nancy A. ;

Park, Chan Young ;

Oezkan, Engin ;

Chakraborty, Chandrani ;

Mulinyawe, Sara B. ;

Annis, Douglas S. ;

Huberman, Andrew D. ;

Green, Eric M. ;

Lawler, Jack ;

Dolmetsch, Ricardo ;

Garcia, K. Christopher ;

Smith, Stephen J. ;

Luo, Z. David ;

Rosenthal, Arnon ;

Mosher, Deane F. ;

Barres, Ben A. .

CELL, 2009, 139 (02) :380-392

[15] Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305 [J].

French, Jacqueline A. ;

Krauss, Gregory L. ;

Steinhoff, Bernhard J. ;

Squillacote, David ;

Yang, Haichen ;

Kumar, Dinesh ;

Laurenza, Antonio .

EPILEPSIA, 2013, 54 (01) :117-125

[16] Adjunctive perampanel for refractory partial-onset seizures Randomized phase III study 304 [J].

French, Jacqueline A. ;

Krauss, Gregory L. ;

Biton, Victor ;

Squillacote, David ;

Yang, Haichen ;

Laurenza, Antonio ;

Kumar, Dinesh ;

Rogawski, Michael A. .

NEUROLOGY, 2012, 79 (06) :589-596

[17] Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities [J].

Garofano, Luciano ;

Migliozzi, Simona ;

Oh, Young Taek ;

D'Angelo, Fulvio ;

Najac, Ryan D. ;

Ko, Aram ;

Frangaj, Brulinda ;

Caruso, Francesca Pia ;

Yu, Kai ;

Yuan, Jinzhou ;

Zhao, Wenting ;

Luisa Di Stefano, Anna ;

Bielle, Franck ;

Jiang, Tao ;

Sims, Peter ;

Suva, Mario L. ;

Tang, Fuchou ;

Su, Xiao-Dong ;

Ceccarelli, Michele ;

Sanson, Marc ;

Lasorella, Anna ;

Iavarone, Antonio .

NATURE CANCER, 2021, 2 (02) :141-156

[18] Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug [J].

Gout, PW ;

Buckley, AR ;

Simms, CR ;

Bruchovsky, N .

LEUKEMIA, 2001, 15 (10) :1633-1640

[19] A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1 [J].

Hai, Ling ;

Hoffmann, Dirk C. ;

Wagener, Robin J. ;

Azorin, Daniel D. ;

Hausmann, David ;

Xie, Ruifan ;

Huppertz, Magnus-Carsten ;

Hiblot, Julien ;

Sievers, Philipp ;

Heuer, Sophie ;

Ito, Jakob ;

Cebulla, Gina ;

Kourtesakis, Alexandros ;

Kaulen, Leon D. ;

Ratliff, Miriam ;

Mandelbaum, Henriette ;

Jung, Erik ;

Jabali, Ammar ;

Horschitz, Sandra ;

Ernst, Kati J. ;

Reibold, Denise ;

Warnken, Uwe ;

Venkataramani, Varun ;

Will, Rainer ;

Suva, Mario L. ;

Herold-Mende, Christel ;

Sahm, Felix ;

Winkler, Frank ;

Schlesner, Matthias ;

Wick, Wolfgang ;

Kessler, Tobias .

NATURE COMMUNICATIONS, 2024, 15 (01)

[20]

Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033

← 1 2 3 4 5 6 7 8 →